KILPEST

3B BlackBio Dx Share Price

 

 

3B BlackBio Dx live price: ₹1217.1.

3B BlackBio Dx Performance

  • Today's Low
  • ₹0
  • Today's High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume
  • 50 DMA₹1,332.17
  • 100 DMA₹1,387.03
  • 200 DMA₹1,433.11

Investment Returns

  • Over 1 Month -2.88%
  • Over 3 Month -16.34%
  • Over 6 Month -12.27%
  • Over 1 Year -29.93%

Smart Investing Starts Here Start SIP with 3B BlackBio Dx for Steady Growth!

Invest Now

3B BlackBio Dx Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

3B BlackBio Dx Financials

3B BlackBio Dx Technicals

EMA & SMA

Current Price
₹1,217.10
+ 15.6 (1.3%)
  • Bearish Moving Average 0
  • Bullish Moving Average 0
  • 20 Day
  • ₹1,239.72
  • 50 Day
  • ₹1,332.17
  • 100 Day
  • ₹1,387.03
  • 200 Day
  • ₹1,433.11

Resistance and Support

1219.93 Pivot Speed
  • R3 1,300.77
  • R2 1,272.88
  • R1 1,247.82
  • S1 1,194.87
  • S2 1,166.98
  • S3 1,141.92

3B BlackBio Dx Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-06 Quarterly Results
2025-11-13 Quarterly Results
2025-08-14 Quarterly Results
2025-05-28 Audited Results & Dividend
2025-02-13 Quarterly Results
Date Purpose Remarks
2025-09-19 FINAL Rs.4.00 per share(40%)Dividend
View 3B BlackBio Dx Dividend History Arrow

3B BlackBio Dx F&O

3B BlackBio Dx Shareholding Pattern

No data available.

3B BlackBio Dx FAQs

3B BlackBio Dx share price is ₹1,217 As on 12 April, 2026 | 09:58

The Market Cap of 3B BlackBio Dx is ₹1044.6 Cr As on 12 April, 2026 | 09:58

The P/E ratio of 3B BlackBio Dx is 18.2 As on 12 April, 2026 | 09:58

The PB ratio of 3B BlackBio Dx is 3.3 As on 12 April, 2026 | 09:58

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23